Literature DB >> 14500497

Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.

Brad Spellberg1, Douglas Johnston, Quynh Trang Phan, John E Edwards, Samuel W French, Ashraf S Ibrahim, Scott G Filler.   

Abstract

We examined the relationship between host survival and renal and splenic immune responses in a murine model of hematogenously disseminated candidiasis. Male BALB/c mice were infected via tail vein injection with wild-type C. albicans or with an isogenic, Deltaefg1/Deltaefg1 hypha-deficient mutant. Host survival, organ fungal burden, intracellular cytokine content of splenic and kidney lymphocytes, and whole-organ cytokine profiles were determined. Wild-type C. albicans induced type 2 splenocyte responses with both nonfatal and fatal inocula. In the kidney, conversely, wild-type inocula causing no or low mortality induced type 1 responses and 100% fatal inocula induced type 2 or interleukin-10 (IL-10)-dominant responses. Hypha-deficient mutant C. albicans caused no or low mortality while inducing type 1 responses in both the spleen and kidney. To our knowledge, this is the first demonstration that host survival during systemic infection correlates with the type of immune response engendered in a nonlymphoid, parenchymal organ and not with the response in the spleen. Furthermore, the results provide in vivo confirmation that hyphal formation by C. albicans induces type 2 or IL-10-dominant host responses in tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500497      PMCID: PMC201094          DOI: 10.1128/IAI.71.10.5756-5764.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Estimating the cost of nosocomial candidemia in the united states.

Authors:  L G Miller; R A Hajjeh; J E Edwards
Journal:  Clin Infect Dis       Date:  2001-04-01       Impact factor: 9.079

2.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

3.  Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells.

Authors:  N Tsuchimori; L L Sharkey; W A Fonzi; S W French; J E Edwards; S G Filler
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 4.  Innate and adaptive immunity in Candida albicans infections and saprophytism.

Authors:  L Romani
Journal:  J Leukoc Biol       Date:  2000-08       Impact factor: 4.962

5.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

6.  Burn-associated Candida albicans infection caused by CD30+ type 2 T cells.

Authors:  M Kobayashi; H Kobayashi; D N Herndon; R B Pollard; F Suzuki
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.

Authors:  Claudia Montagnoli; Angela Bacci; Silvia Bozza; Roberta Gaziano; Paolo Mosci; Arlene H Sharpe; Luigina Romani
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

9.  In situ upregulation of IL-10 reflects the activity of human glomerulonephritides.

Authors:  Z I Niemir; M Ondracek; G Dworacki; H Stein; R Waldherr; E Ritz; H F Otto
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

10.  Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans.

Authors:  P Chiani; C Bromuro; A Torosantucci
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

View more
  33 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.

Authors:  Brad J Spellberg; Ashraf S Ibrahim; Valentina Avenissian; Scott G Filler; Carter L Myers; Yue Fu; John E Edwards
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans.

Authors:  Shuichi Ito; Joao Pedras-Vasconcelos; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.

Authors:  Brad Spellberg; Ashraf S Ibrahim; Lin Lin; Valentina Avanesian; Yue Fu; Peter Lipke; Henry Otoo; Tiffany Ho; John E Edwards
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

Review 5.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

6.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

7.  Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.

Authors:  Casey T Nishiya; Gayle M Boxx; Kerry Robison; Carol Itatani; Thomas R Kozel; Mason X Zhang
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

8.  Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.

Authors:  Lin Lin; Ashraf S Ibrahim; Xin Xu; Joshua M Farber; Valentina Avanesian; Beverlie Baquir; Yue Fu; Samuel W French; John E Edwards; Brad Spellberg
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

9.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

10.  Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.

Authors:  Donna M MacCallum; Luis Castillo; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.